NADH/NADPH oxidase p22 phox C242T polymorphism and coronary artery disease in the Australian population

European Journal of Clinical Investigation

Volumn 29, Issue 9, 1999, Pages 744-748

  Cai, H ^a   Duarte, N ^a   Wilcken, D E L ^a   Wang, Xing Li ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Coronary artery disease; Ethnic difference; NADH NADPH p22 phox polymorphism

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ADULT; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POPULATION GENETICS; PRIORITY JOURNAL; SEX DIFFERENCE;

AUSTRALIA; CORONARY ANGIOGRAPHY; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NADPH DEHYDROGENASE; NADPH OXIDASE; PHOSPHOPROTEINS; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS;

EID: 0032834924     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00531.x     Document Type: Article

References (9)

1. Segal AW, Shatwell KP. The NADPH oxidase of phagocytic leukocytes. Ann N Y Acad Sci 1997; 832:215-22.
2. Mohazzab HKM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiolol 1994; 266: H2568-H2578.
3. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74:1141-8.
4. phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996; 271:23317-21.
5. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q 4th, Taylor WR et al. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Cir Res 1997; 80:45-51.
6. Alexander RW. Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995; 25:155-61.
7. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymotphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998; 97:135-7.
8. Jones SA, O'Donnell VB, Wood JD, Broughton JP, Hughes EJ, Jones OTG. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol 1996; 271:H1626-H1634.
9. Wang XL, Sim AS, Badenhop R, McCredie MR, Wilcken DEL. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med 1996; 2:41-5.